CN101675803B - 一种幼少儿人群复合冲剂 - Google Patents
一种幼少儿人群复合冲剂 Download PDFInfo
- Publication number
- CN101675803B CN101675803B CN2008100717517A CN200810071751A CN101675803B CN 101675803 B CN101675803 B CN 101675803B CN 2008100717517 A CN2008100717517 A CN 2008100717517A CN 200810071751 A CN200810071751 A CN 200810071751A CN 101675803 B CN101675803 B CN 101675803B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- aliphatic acid
- acid
- electuary
- young children
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 12
- 239000002131 composite material Substances 0.000 title abstract 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 34
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 24
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 24
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 23
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 22
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000015097 nutrients Nutrition 0.000 claims abstract description 21
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 12
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims abstract description 12
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 12
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 12
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 12
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 12
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 12
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 12
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 12
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 12
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 12
- 239000011648 beta-carotene Substances 0.000 claims abstract description 12
- 229960002747 betacarotene Drugs 0.000 claims abstract description 12
- 229960002685 biotin Drugs 0.000 claims abstract description 12
- 235000020958 biotin Nutrition 0.000 claims abstract description 12
- 239000011616 biotin Substances 0.000 claims abstract description 12
- 239000011575 calcium Substances 0.000 claims abstract description 12
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 12
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960001231 choline Drugs 0.000 claims abstract description 12
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 12
- 239000011651 chromium Substances 0.000 claims abstract description 12
- 229960000304 folic acid Drugs 0.000 claims abstract description 12
- 235000019152 folic acid Nutrition 0.000 claims abstract description 12
- 239000011724 folic acid Substances 0.000 claims abstract description 12
- 229960000367 inositol Drugs 0.000 claims abstract description 12
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 12
- 239000011777 magnesium Substances 0.000 claims abstract description 12
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 12
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 12
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 12
- 239000011570 nicotinamide Substances 0.000 claims abstract description 12
- 239000011574 phosphorus Substances 0.000 claims abstract description 12
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 12
- 229960003471 retinol Drugs 0.000 claims abstract description 12
- 235000020944 retinol Nutrition 0.000 claims abstract description 12
- 239000011607 retinol Substances 0.000 claims abstract description 12
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000011669 selenium Substances 0.000 claims abstract description 12
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 12
- 239000011701 zinc Substances 0.000 claims abstract description 12
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 12
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 12
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 11
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 11
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 11
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 10
- 239000011719 vitamin A Substances 0.000 claims abstract description 10
- 229940045997 vitamin a Drugs 0.000 claims abstract description 10
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract description 9
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims abstract description 3
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 3
- 239000011710 vitamin D Substances 0.000 claims abstract description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 3
- 229940046008 vitamin d Drugs 0.000 claims abstract description 3
- 239000002253 acid Substances 0.000 claims description 34
- 125000001931 aliphatic group Chemical group 0.000 claims description 34
- 150000001875 compounds Chemical class 0.000 claims description 24
- 239000002994 raw material Substances 0.000 claims description 12
- 229910052742 iron Inorganic materials 0.000 claims description 11
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 9
- 229910052748 manganese Inorganic materials 0.000 claims description 9
- 239000011572 manganese Substances 0.000 claims description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 8
- 229910052740 iodine Inorganic materials 0.000 claims description 8
- 239000011630 iodine Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 6
- 235000013351 cheese Nutrition 0.000 claims description 6
- 230000000366 juvenile effect Effects 0.000 claims description 6
- 230000007115 recruitment Effects 0.000 claims description 6
- 235000013402 health food Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 235000016709 nutrition Nutrition 0.000 abstract description 12
- 235000015872 dietary supplement Nutrition 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 abstract 2
- 229940012843 omega-3 fatty acid Drugs 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 230000021332 multicellular organism growth Effects 0.000 abstract 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 abstract 1
- 229940033080 omega-6 fatty acid Drugs 0.000 abstract 1
- 235000019175 phylloquinone Nutrition 0.000 abstract 1
- 239000011772 phylloquinone Substances 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 abstract 1
- 229960001898 phytomenadione Drugs 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 230000036541 health Effects 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000003912 environmental pollution Methods 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000037213 diet Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229940023136 pantothenic acid 10 mg Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种幼少儿人群复合冲剂型最佳营养补充剂。一种幼少儿人群复合冲剂型最佳营养补充剂是以维生素A：视黄醇、β-胡萝卜素、维生素D、E、K1、C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇、GLAomega -6脂肪酸，EPA omega-3脂肪酸、DHAomega-3脂肪酸，钙、镁、铁、锌、锰、碘、铬、硒、磷28种营养素组合的全营养素保健食品。幼少儿人群复合冲剂型最佳营养补充剂是以21世纪最新营养科学结合最新医学科学为基本原理，国际创新的最佳营养补充配方，是促使幼儿少儿的智力与身体健康发育成长的最佳营养补充良方A型复合冲剂适宜1-2周岁幼儿，B型复合冲剂适宜3-4周岁幼儿、C型复合冲剂适宜5-6周岁少儿。
Description
技术领域
本发明属于一种三类不同年龄段的幼少儿最佳营养补充剂保健品
背景技术
保健品的发展是衡量一个国家或地区人民的健康程度和生活质量的鲜明特征之一。随着生活水平提高和社会活动节奏加快，精神压力、工作压力、环境污染与生活方式不佳，缺乏运动，偏营养饮食习惯，传统的非健康烹调方式，使维生素必须脂肪酸大量的损失，能量营养素大量过剩，维生素、矿物质必需脂肪酸和抗氧化物质的缺乏量剧增，富贵病(现代文明病)越来越多，亚健康状况越来越严重，生活水平大幅提高，健康水平反而下降。另一方面是随着科学水平的高速发展，地下能源的大量开发利用，二氧化碳排放量大幅增加，气候环境变暖，全球环境受到严重污染，从空气、水源、噪声、光源、电磁波、化学工业、汽车尾气、农药化肥、土壤、食物、食物连等受到不同程度的污染，食物生长期缩短，食物原料自然反营养物质与环境污染的反营养物质剧增，药品抗生素类的反营养物质，生活方式不佳引起的反营养物质也同时剧增，严重影响了人类饮食的营养与健康，人类体内自身合成功能的退化，各种营养素损耗指数的增加，人体的营养消耗量也大幅增加，为了洁抗环境污染、精神压力、工作压力、抗生素药类，不佳的生活方式，人类必须要消耗大量的营养元素，人体的必需营养素缺泛量越来越大，这是抵抗与免疫产生的自然现象，国家的推荐量(DRIs)与现代国际最佳营养的研究差距越来越大。我们研究的ABCDRIS健康饮食项目与ABCODAC最佳营养补充项目是一对同胞姐妹项目，随着营养科学和医学科学的不断发展，人类的健康必须要采用ABCDRIS健康饮食和ABCODAC最佳营养补充，结合最佳科学健康的生活方式(优美环境、适量运动，充足睡眠、心态平衡，生活规律、安全卫生、预防污染、防灾抗灾、灾难自救等)这样人类才会健康与长寿，国人健康国家强盛。
发明内容
本发明的目的在于弥补现有污染环境下与现有膳食习惯中营养素的明显不足，缺乏量很大的情况下，来补充人类各种人群的健康营养，使各类人群能达到最佳营养，更是创造了一种现代健康理想的营养补充剂保健食品。来促进幼少儿人群健康的发育成长，成为中华民族最健康的接班人。
本发明的目的是这样实现的：所述的一种幼少儿人群复合冲剂是以：视黄醇、β-胡萝卜素、维生素D、E、K1、C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇、GLAomega-6脂肪酸，EPAomega-3脂肪酸、DHAomega-3脂肪酸，钙、镁、铁、锌、锰、碘、铬、硒、磷28种营养素组合的全营养素保健食品。
1、一种适宜1-2周岁幼儿复合冲剂，具体原料配方包括如下：
维生素A：视黄醇360-600ug、β-胡萝卜素540——900ug、维生素D1.125-1.875ug、E11.25-18.75mg、K12.25-3.75ug、C75-125mg、B13.75-6.25mg、B23.75-6.25mg、B64.5-7.5mg、B124.5-7.5ug、烟酰胺9-15mg、泛酸7.5-12.5mg、叶酸75-125ug、生物素30-50ug、胆碱10.5-17.5mg、肌醇10.5-17.5mg、GLAomega-6脂肪酸60-100mg、EPA/omega-3脂肪酸112.5-187.5mg、DHAomega-3脂肪酸93.75-156.25mg、钙127.5-212.5mg、镁52.5-87.5mg、铁3.75-6.25mg、锌3.75-6.25mg、锰262.5-437.5ug、碘56.25-93.75ug、铬15-25ug、硒11.25-18.75ug、磷11.25-18.75mg；
2、一种适宜3-4周岁幼儿复合冲剂，具体原料配方包括如下：
维生素A：视黄醇420-700ug、β-胡萝卜素630——1050ug、维生素D1.3125-2.1875ug、E15-25mg、K14.5-7.5ug、C150-250mg、B15.25-8.75mg、B25.25-8.75mg、B67.5-12.5mg、B125.25-8.75ug、烟酰胺10.5-17.5mg、泛酸11.25-18.75mg、叶酸90-150ug、生物素37.5-62.5ug、胆碱12-20mg、肌醇12-20mg、GLAomega--6脂肪酸71.25-118.75mg、EPAomega-3脂肪酸150-250mg、DHAomega-3脂肪酸112.5-187.5mg、钙135-225mg、镁60-100mg、铁4.5-7.5mg、锌4.5-7.5mg、锰300-500ug、碘75-125ug、铬17.25-28.75ug、硒15-25ug、磷15-25mg；
3、一种适宜5-6周岁少儿复合冲剂，具体原料配方包括如下：
维生素A：视黄醇480-800ug、β-胡萝卜素720-1200ug、维生素D1.5-2.5ug、E18.75-31.25mg、K17.5-12.5ug、C225-375mg、B16.75-11.25mg、B26.75-11.25mg、B69-15mg、B126-10ug、烟酰胺12-20mg、泛酸15-25mg、叶酸105-175ug、生物素45-75ug、胆碱13.5-22.5mg、肌醇13.5-22.5mg、GLAomega-6脂肪酸82.50-137.5mg、EPA omega-3脂肪酸187.5-312.5mg、DHAomega-3脂肪酸131.25-218.75mg、钙142.5-237.5mg、镁67.5-112.5mg、铁5.25-8.75mg、锌5.25-8.75mg、锰375-625ug、碘93.75-156.25ug、铬18.75-31.25ug、硒18.75-31.25ug、磷18.75-31.25mg；
上述配方中的原料都选择优质符合国家标准的上等原料，精心采购，严格把关，原料安全，质量优秀，含量标准。
本发明的幼少儿人群复合冲剂即有天然营养素与人工合成营养素组合。本发明的目的是为了让三类不同年龄段幼少儿人群各需不同的最佳营养补充摄入量。
本发明的幼少儿人群复合冲剂是三类人群最佳的健康营养补充，是发育成长的最佳营养，能促使幼少儿最佳健康的发育成长。
本发明的幼少儿人群复合冲剂是纯营养素组合，食用安全，方便，容易吸收，适宜幼少儿人群。
下面结合实例，对本发明加以进一步说明：
实例一：适宜1-2周岁幼儿人群复合冲剂，原料配方与制备：
维生素A：视黄醇480ug、β-胡萝卜素720ug、维生素D1.5ug、E15mg、K13ug、C100mg、B15mg、B25mg、B66mg、B126ug、烟酰胺12mg、泛酸10mg、叶酸100ug、生物素40ug、胆碱14mg、肌醇14mg、GLAomega-6脂肪酸80mg、EPA/omega-3脂肪酸150mg、DHAomega-3脂肪酸125mg、钙170mg、镁70mg、铁5mg、锌5mg、锰350ug、碘75ug、铬20ug、硒15ug、磷15mg；
实例二：适宜3-4周岁幼儿人群复合冲剂，原料配方与制备：
维生素A：视黄醇560ug、β-胡萝卜素840ug、维生素D1.75ug、E20mg、K16ug、C200mg、B17mg、B27mg、B610mg、B127ug、烟酰胺14mg、泛酸15mg、叶酸120ug、生物素50ug、胆碱16mg、肌醇16mg、GLAomega-6脂肪酸95mg、EPAomega-3脂肪酸200mg、DHAomega-3脂肪酸150mg、钙180mg、镁80mg、铁6mg、锌6mg、锰400ug、碘100ug、铬23ug、硒20ug、磷20mg；
实例三：适宜5-6周岁少儿人群复合冲剂，原料配方与制备：
维生素A：视黄醇640ug、β-胡萝卜素960ug、维生素D2ug、E25mg、K110ug、C300mg、B19mg、B29mg、B612mg、B128ug、烟酰胺16mg、泛酸20mg、叶酸140ug、生物素60ug、胆碱18mg、肌醇18mg、GLAomega-6脂肪酸110mg、EPA omega-3脂肪酸250mg、DHAomega-3脂肪酸175mg、钙190mg、镁90mg、铁7mg、锌7mg、锰500ug、碘125ug、铬25ug、硒25ug、磷25mg；
一种幼少儿人群复合冲剂的制备工艺包括如下步聚：
适宜1-2周岁幼儿复合冲剂
将所有的营养素原料组合附加适合幼少儿口味的糖类，奶酪、香料类等不影响吸收为原则加工成饮品冲剂，A型冲剂为一包6克定为1-2周岁幼儿的一天补充量。
适宜3-4周岁幼儿复合冲剂
将所有的营养素原料组合附加适合幼少儿口味的糖类，奶酪、香料类等不影响吸收为原则加工成饮品冲剂，B型冲剂为一包8克定为3-4周岁幼儿的一天补充量。
适宜5-6周岁少儿复合冲剂
将所有的营养素原料组合附加适合幼少儿口味的糖类，奶酪、香料类等不影响吸收为原则加工成饮品冲剂，C型冲剂为一包10克定为5-6周岁少儿的一天补充量。
最佳服用方式：A、B、C三类冲剂可分早、午餐进食时1-2次饮用，每种复合冲剂的营养成分就是原料的营养成分，是各类人群每天必须补充的摄入量。目前经济发达的地区，一般传统的饮食习惯，都会导致能量营养素(脂肪、蛋白质、碳水化合物)过剩，超重与肥胖的人比例上升较快，这是走入亚健康的前兆，必须要控制它，能量营养素的质与量必须要平衡，一定要与自己的每日活动量达到平衡。目前幼少儿肥胖现象较少，少年儿童中有小部分已成为肥胖者，能量营养过剩，对少年儿童的发育成长是很不利的，应该要大力控制它，否者后果不甚设想。
复合冲剂的研究成功，首先是国内专家的合作，又得到了国际最高权威英美专家的支持，是一个新世纪的健康大革命，是新世纪人类健康最佳营养补充的良方，是一个促进幼少儿健康发育成长，促使国人健康长寿，促进国家强盛发达的科学发展的方向，国人健康，国家强盛。
Claims (7)
1.一种幼少儿人群复合冲剂，是以视黄醇、β-胡萝卜素、维生素D、E、K1、C、B1、B2、B6、B12、烟酰胺、泛酸、叶酸、生物素、胆碱、肌醇、GLAomega-6脂肪酸，EPAomega-3脂肪酸、DHAomega-3脂肪酸、钙、镁、铁、锌、锰、碘、铬、硒、磷28种营养素组合的全营养素保健食品。
2.一种适宜1-2周岁幼儿复合冲剂，具体原料配方包括如下：
维生素A：视黄醇360-600ug、β-胡萝卜素540——900ug、维生素D1.125-1.875ug、E11.25-18.75mg、K12.25-3.75ug、C75-125mg、B13.75-6.25mg、B23.75-6.25mg、B64.5-7.5mg、B124.5-7.5ug、烟酰胺9-15mg、泛酸7.5-12.5mg、叶酸75-125ug、生物素30-50ug、胆碱10.5-17.5mg、肌醇10.5-17.5mg、GLAomega-6脂肪酸60-100mg、EPA/omega-3脂肪酸112.5-187.5mg、DHAomega-3脂肪酸93.75-156.25mg、钙127.5-212.5mg、镁52.5-87.5mg、铁3.75-6.25mg、锌3.75-6.25mg、锰262.5-437.5ug、碘56.25-93.75ug、铬15-25ug、硒11.25-18.75ug、磷11.25-18.75mg。
3.一种适宜3-4周岁幼儿复合冲剂，具体原料配方包括如下：
维生素A：视黄醇420-700ug、β-胡萝卜素630——1050ug、维生素D1.3125-2.1S75ug、E15-25mg、K14.5-7.5ug、C150-250mg、B15.25-8.75mg、B25.25-8.75mg、B67.5-12.5mg、B125.25-8.75ug、烟酰胺10.5-17.5mg、泛酸11.25-18.75mg、叶酸90-150ug、生物素37.5-62.5ug、胆碱12-20mg、肌醇12-20mg、GLAomega-6脂肪酸71.25-118.75mg、EPA omega-3脂肪酸150-250mg、DHAomega-3脂肪酸112.5-187.5mg、钙135-225mg、镁60-100mg、铁4.5-7.5mg、锌4.5-7.5mg、锰300-500ug、碘75-125ug、铬17.25-28.75ug、硒15-25ug、磷15-25mg。
4.一种适宜5-6周岁少儿复合冲剂，具体原料配方包括如下：
维生素A：视黄醇480-800ug、β-胡萝卜素720-1200ug、维生素D1.5-2.5ug、E18.75-31.25mg、K17.5-12.5ug、C225-375mg、B16.75-11.25mg、B26.75-11.25mg、B69-15mg、B126-10ug、烟酰胺12-20mg、泛酸15-25mg、叶酸105-175ug、生物素45-75ug、胆碱13.5-22.5mg、肌醇13.5-22.5mg、GLAomega-6脂肪酸82.50-137.5mg、EPA omega-3脂肪酸187.5-312.5mg、DHAomega-3脂肪酸131.25-218.75mg、钙142.5-237.5mg、镁67.5-112.5mg、铁5.25-8.75mg、锌5.25-8.75mg、锰375-625ug、碘93.75-156.25ug、铬18.75-31.25ug、硒18.75-31.25ug、磷18.75-31.25mg。
5.权利要求2所述的复合冲剂的制作工艺，包括如下步骤：将所有的营养素原料组合附加适合幼少儿口味的糖类，奶酪、香料类等不影响吸收为原则加工成饮品冲剂，A型冲剂为一包6克定为1-2周岁幼儿的一天补充量。
6.权利要求3所述的复合冲剂的制作工艺，包括如下步骤：将所有的营养素原料组合附加适合幼少儿口味的糖类，奶酪、香料类等不影响吸收为原则加工成饮品冲剂，B型冲剂为一包8克定为3-4周岁幼儿的一天补充量。
7.权利要求4所述的复合冲剂的制作工艺，包括如下步骤：将所有的营养素原料组合附加适合幼少儿口味的糖类，奶酪、香料类等不影响吸收为原则加工成饮品冲剂，C型冲剂为一包10克定为5-6周岁少儿的一天补充量。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100717517A CN101675803B (zh) | 2008-09-16 | 2008-09-16 | 一种幼少儿人群复合冲剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100717517A CN101675803B (zh) | 2008-09-16 | 2008-09-16 | 一种幼少儿人群复合冲剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101675803A CN101675803A (zh) | 2010-03-24 |
| CN101675803B true CN101675803B (zh) | 2013-12-11 |
Family
ID=42028643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100717517A Expired - Fee Related CN101675803B (zh) | 2008-09-16 | 2008-09-16 | 一种幼少儿人群复合冲剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101675803B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2959644B1 (fr) * | 2010-05-07 | 2014-06-20 | Deenox Sas | Nouvelle composition comprenant des omega-3 et son utilisation dans la gueule de bois |
| CN103371421B (zh) * | 2012-04-26 | 2014-09-17 | 郭涛 | 保健饮料 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1422553A (zh) * | 2001-12-06 | 2003-06-11 | 上海黄金搭档生物科技有限公司 | 女士维生素、矿物质营养组合物 |
| CN1429077A (zh) * | 2000-05-18 | 2003-07-09 | 斯博茨科姆丹麦私人有限公司 | 用于膳食补充物的营养组合物 |
| CN1593229A (zh) * | 2004-07-09 | 2005-03-16 | 曹永文 | 生物营养保健素及制作方法及含有生物营养保健素的产品 |
| CN1893841A (zh) * | 2004-12-28 | 2007-01-10 | 日商富地滋股份有限公司 | 健康饮料 |
-
2008
- 2008-09-16 CN CN2008100717517A patent/CN101675803B/zh not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1429077A (zh) * | 2000-05-18 | 2003-07-09 | 斯博茨科姆丹麦私人有限公司 | 用于膳食补充物的营养组合物 |
| CN1422553A (zh) * | 2001-12-06 | 2003-06-11 | 上海黄金搭档生物科技有限公司 | 女士维生素、矿物质营养组合物 |
| CN1593229A (zh) * | 2004-07-09 | 2005-03-16 | 曹永文 | 生物营养保健素及制作方法及含有生物营养保健素的产品 |
| CN1893841A (zh) * | 2004-12-28 | 2007-01-10 | 日商富地滋股份有限公司 | 健康饮料 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101675803A (zh) | 2010-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101675804B (zh) | 一种未成年人组合胶囊 | |
| CN102113535A (zh) | 一种辣木营养饼干 | |
| CN101675805B (zh) | 一种中老年人组合胶囊 | |
| Priyanka et al. | Spirulina: A spotlight on its nutraceutical properties and food processing applications | |
| CN103907936B (zh) | 一种高蛋白组合物及其制备方法和应用 | |
| CN101675806B (zh) | 一种成年人组合胶囊 | |
| CN104095897A (zh) | 一种玛咖盐藻复方制剂 | |
| CN101675803B (zh) | 一种幼少儿人群复合冲剂 | |
| CN102028223A (zh) | 含酵母型营养素补充剂的一组强化食品 | |
| CN102613482A (zh) | 婴儿辅食营养挂面及生产方法 | |
| Valyasevi et al. | Studies of Bladder Stone Disease in Thailand: IV. Dietary Habits, Nutritional Intake, and Infant Feeding Practices Among Residents of a Hypo-and Hyperendemic Area | |
| CN105613972A (zh) | 一种富维生素b2鸡蛋的生产方法 | |
| CN102423003A (zh) | 一种低胆固醇、富硒、富维生素b2鸡蛋的生产方法 | |
| CN105166905A (zh) | 一种复方减肥粉及其制备方法 | |
| CN102366102B (zh) | 一种适合于肿瘤患者食用的食品 | |
| CN103766891A (zh) | 一种正分子营养青少年学生专用营养口服液 | |
| Jony et al. | Eggshells calcium extraction and the application in food fortifications | |
| CN105077018A (zh) | 一种椰奶海鲜咖哩口味的方便面 | |
| CN103766890A (zh) | 一种正分子营养运动员教练员专用营养口服液 | |
| CN102150837A (zh) | 亚铁血红素肽咀嚼片配方及制作方法 | |
| Soliboeva | Functional food products a promising direction of new innovative technologies in dietary | |
| RU2537906C2 (ru) | Способ обогащения магнием плодов и ягод | |
| Ivannikova et al. | The use of spirulina in vegetable juices | |
| Sanders | Vegetarianism: dietetic and medical aspects | |
| CN101044899B (zh) | 姜氨基酸保健饮料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Sun Zhigang Document name: payment instructions |
|
| DD01 | Delivery of document by public notice |
Addressee: Sun Zhigang Document name: payment instructions |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Sun Zhigang Document name: Notice of Termination of Patent Rights |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131211 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |